7DU-18265-84170
4 vaccinations
6 coded responses
44 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 461 / IN
- Registered
- 2021-03-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-07
Registered in v-safe
-
2021-03-07
Dose 1 — Pfizer-BioNTech
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-13
- 2021-03-14
- 2021-03-21
-
2021-03-28
Dose 2 — Pfizer-BioNTech
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-11
- 2021-04-18
- 2021-04-27
- 2021-05-03
- 2021-05-09
-
2021-06-27
Survey response — 3 months, dose 2MedDRA: Ageusia, Anosmia, Fatigue, Nasal congestion, Nasopharyngitis, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I tested positive for covid 19 on may 30th. I had a fever of 100.4, no sense of taste or smell, runny nose and stopped up nose. Also fatigue. My symptoms were pretty mild and went away within about two days. I had cold symptoms for about five days.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-27
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-05
- 2021-09-26
-
2021-11-14
Dose 3 — Pfizer-BioNTech
-
2021-11-14
Survey response — day 0, dose 3MedDRA: Dysgeusia, Immediate post-injection reaction — Feeling: GoodFree text: Metallic taste right after vaccineMedDRA releases: 2024-11 · check-in free text available
-
2021-11-15
Survey response — days 1–6 daily, dose 3MedDRA: Dysgeusia — Feeling: Fair · Site: Pain · Fever · Fatigue or tirednessFree text: A little bit of metallic taste left over.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-16
- 2021-11-17
- 2021-11-19
- 2021-11-20
-
2021-11-21
Survey response — day 7, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Lymph nodes on breasts are swollenMedDRA releases: 2024-11 · check-in free text available
- 2021-11-28
- 2021-12-05
- 2021-12-12
- 2021-12-19
- 2021-12-26
- 2022-02-13
-
2022-05-15
Survey response — 6 months, dose 3MedDRA: Adverse reaction, Nasopharyngitis, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend schoolFree text: I started to develop allergy/cold symptoms. Tested for covid and it came back as positive. This was one week agoMedDRA releases: 2024-11 · check-in free text available
-
2022-12-10
Dose 4 — Pfizer-BioNTech
- 2022-12-19
- 2022-12-24
- 2022-12-31
- 2023-01-07
- 2023-01-14
-
2023-01-21
Survey response — day 42, dose 4MedDRA: Nasopharyngitis, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test negative, Sneezing — Feeling: FairMedDRA releases: 2024-11
- 2023-03-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-07 | Pfizer-BioNTech | |
| 2 | 2021-03-28 | Pfizer-BioNTech | |
| 3 | 2021-11-14 | Pfizer-BioNTech | No |
| 4 | 2022-12-10 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — 3 months, dose 2
Symptoms: I tested positive for covid 19 on may 30th. I had a fever of 100.4, no sense of taste or smell, runny nose and stopped up nose. Also fatigue. My symptoms were pretty mild and went away within about two days. I had cold symptoms for about five days. cut off by CDC
Release 10 — day 0, dose 3
Systemic reaction (other): Metallic taste right after vaccine
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): A little bit of metallic taste left over.
Release 10 — day 7, dose 3
Systemic reaction (other): Lymph nodes on breasts are swollen
Release 11 — 6 months, dose 3
Symptoms: I started to develop allergy/cold symptoms. Tested for covid and it came back as positive. This was one week ago
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Adverse reaction | · | · | ✓ |
| SD | Ageusia | ✓ | ✓ | ✓ |
| SD | Anosmia | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | ✓ | ✓ | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Dysgeusia | · | · | ✓ |
| SRO | Immediate post-injection reaction | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release